AMPK agonism optimizes the in vivo activation and antileukemic efficacy of chimeric antigen receptor T cells
J Immunother Cancer. 2025 Dec 21;13(12):e010312. doi: 10.1136/jitc-2024-010312. ABSTRACT BACKGROUND: Chimeric antigen receptor (CAR) T cells have achieved remarkable clinical […]
